CTRI/2022/11/047051Not yet recruiting未知
A STUDY TO IDENTIFY POTENTIAL DRUG-DRUG INTERACTION AMONG PSYCHIATRY INPATIENTS IN A TERTIARY HEALTHCARE CENTRE
il0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
Inclusion Criteria
- •Participants of either gender, age 18 years or above, admitted in the department of psychiatry, prescribed with at least two drugs(one of which was from the psychotropic class).
- •All the participants with a psychiatric diagnosis as per the Tenth Revision of the International Classification of Diseases (ICD 10)
Exclusion Criteria
- •Participants referred to the psychiatric unit for evaluation.
- •Participants or guardian not willing to give consent.
- •Topical agents and drugs which were not included in any of the reference resources.
Investigators
Similar Trials
Completed
Not Applicable
Drug-drug interaction study to explore importance of CYP3A4 and OATP1B1 as factors determining pharmacokinetics of atorvastatihealthy male subjectsJPRN-UMIN000002477Clinical trial Center,Kitsato University East Hospital8
Completed
Not Applicable
A Drug-Drug Interaction, Safety and Efficacy Study With JNJ-56021927 (ARN-509) and Abiraterone Acetate in Subjects With Metastatic Castration-Resistant Prostate Cancer10036958prostate cancerNL-OMON44408Johnson & Johnson Pharmaceutical10
Completed
Phase 2
Clinical Pharmacology Study -Drug-Drug Interaction Study of CNT-01Idiopathic triglyceride deposit cardiomyovasculopathyJPRN-jRCT2031220678Akita Yasuhiko32
Completed
Not Applicable
A study examining the pharmacodynamic interaction between buprenorphine and fentanylNL-OMON46809Indivior UK Ltd.22
Completed
Not Applicable
Independent study: Researching drug-drug interaction bitween etizolam and itraconazoleeurosis, somnipathyJPRN-UMIN000011279P-One Clinic, Keikokai Medical Corp16